Smart Materials for Smart Treatments
Turning Postoperative Dressings Into Active Infection Management
Helping hospitals reduce surgical site infection-related readmissions, without disrupting clinical workflow.
Discover EnzyLock
Surgical Site Infections Remain a Costly, Preventable Complication
One preventable infection can trigger longer hospital stays, readmissions, higher costs, and worse patient outcomes, while straining hospital quality metrics.
~0K
SSI-Related Readmissions Annually
In the U.S. alone, driving prolonged antibiotic use
+0.0 days
Added Length of Stay per Readmission
Extending recovery and hospital resource use
~$0K
Additional Cost per SSI
In direct hospital utilization and treatment costs
$0B
Annual U.S. Healthcare Costs from SSIs
Across hospital systems nationwide
Up to 0x
Higher Mortality Risk with SSI
Compared to patients without a surgical site infection
+0 days
Delayed Healing with Untreated Infection
Prolonging recovery and time to discharge
Sources: NHSN 2019 SSI Protocol (CDC); de Lissovoy G, Fraeman K, Hutchins V. "Surgical site infection: Incidence and impact on hospital utilization and treatment costs." Am J Infect Control, 2009; Guest JF, Fuller GW, Griffiths B. BMJ Open, 2023.
The Problem
Surgical site infections remain a costly and preventable complication of surgery. Once an incision is closed, clinicians have few tools to respond to early bacterial contamination before it progresses, leading to prolonged antibiotic use, extended hospital stays, and readmissions.
Our Vision
At Red Maple LifeSciences, we are turning the postoperative dressing into an active infection management tool, one that responds to the biology of the wound itself and fits into existing surgical workflows with no added steps for clinical staff.
EnzyLock Smart Hydrogel Platform
The platform integrates two core functions: a bacteria-responsive indicator that signals infection through visible color change, and localized antimicrobial therapy that releases only when bacteria are present.
EnzyLock replaces standard postoperative dressings with no changes to surgical or monitoring workflow, so hospitals can adopt it without disrupting existing care.
Learn More
Backed by World-Class Institutions
“EnzyLock represents a fundamentally new approach to wound care, one that responds to the biology of the wound itself.”
Red Maple LifeSciences Advisory Board